Balance Sheet Data
Regeneron Pharmaceuticals, Inc. (REGN)
$815.375
-8.44 (-1.02%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 4,564.90 | 6,471.10 | 6,722.60 | 12,532.70 | 14,334.10 | 12,683.10 | 15,540.57 | 19,041.81 | 23,331.86 | 28,588.46 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 2,243.20 | 2,672.20 | 4,114.70 | 6,036.50 | 5,328.70 | 5,881.72 | 7,206.85 | 8,830.53 | 10,820.02 | 13,257.74 |
| Account Receivables (%) | ||||||||||
| Inventories | 1,151.20 | 1,415.50 | 1,916.60 | 1,951.30 | 2,401.90 | 2,672.37 | 3,274.45 | 4,012.17 | 4,916.10 | 6,023.68 |
| Inventories (%) | ||||||||||
| Accounts Payable | 218.20 | 418.10 | 475.50 | 564 | 589.20 | 671.61 | 822.93 | 1,008.33 | 1,235.50 | 1,513.86 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -383.10 | -429.60 | -614.60 | -551.90 | -590.10 | -796.09 | -975.44 | -1,195.21 | -1,464.48 | -1,794.42 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.